Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy

An exploratory study

Chien Han Lai, Yu Te Wu, Cheng Yu Chen, Yi Cheng Hou

Research output: Contribution to journalArticle

Abstract

We investigated the treatment effects of aripiprazole monotherapy in first-episode medication-naïve patients with major depressive disorder (MDD). The accompanying changes in the gray matter volume (GMV) were also explored.Fifteen patients completed the trial and received structural scans by 3-Tesla magnetic resonance imaging at baseline and partially responding state (sixth week). To account for the test-retest bias, 27 healthy controls were scanned twice within 6 weeks. We utilized optimized voxel-based morphometry with different comparisons between groups.The partially responding patients with MDD had greater GMV in left middle frontal gyrus and left superior parietal gyrus when compared with baseline. However, they had decreases in the GMV of right orbitofrontal gyrus and right inferior temporal gyrus after response. The partially responding patients with MDD still had residual GMV deficits in right superior frontal gyrus when compared with controls. However, the lack of second patient group without aripiprazole intervention would be a significant limitation to interpret the aripiprazole-specific effects on GMV.The changes in the GMV of fronto-parieto-temporal regions and residual GMV deficits in the superior frontal gyrus might represent "state-dependent brain changes" and "residual-deficit brain regions," respectively, for aripiprzole monotherapy in MDD.

Original languageEnglish
Pages (from-to)e4654
JournalMedicine
Volume95
Issue number34
DOIs
Publication statusPublished - Aug 1 2016
Externally publishedYes

Fingerprint

Parietal Lobe
Depression
Major Depressive Disorder
Prefrontal Cortex
Temporal Lobe
Brain
Aripiprazole
Gray Matter
Magnetic Resonance Imaging

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy : An exploratory study. / Lai, Chien Han; Wu, Yu Te; Chen, Cheng Yu; Hou, Yi Cheng.

In: Medicine, Vol. 95, No. 34, 01.08.2016, p. e4654.

Research output: Contribution to journalArticle

@article{389099719ffd4baab253ee87337d4c78,
title = "Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy: An exploratory study",
abstract = "We investigated the treatment effects of aripiprazole monotherapy in first-episode medication-na{\"i}ve patients with major depressive disorder (MDD). The accompanying changes in the gray matter volume (GMV) were also explored.Fifteen patients completed the trial and received structural scans by 3-Tesla magnetic resonance imaging at baseline and partially responding state (sixth week). To account for the test-retest bias, 27 healthy controls were scanned twice within 6 weeks. We utilized optimized voxel-based morphometry with different comparisons between groups.The partially responding patients with MDD had greater GMV in left middle frontal gyrus and left superior parietal gyrus when compared with baseline. However, they had decreases in the GMV of right orbitofrontal gyrus and right inferior temporal gyrus after response. The partially responding patients with MDD still had residual GMV deficits in right superior frontal gyrus when compared with controls. However, the lack of second patient group without aripiprazole intervention would be a significant limitation to interpret the aripiprazole-specific effects on GMV.The changes in the GMV of fronto-parieto-temporal regions and residual GMV deficits in the superior frontal gyrus might represent {"}state-dependent brain changes{"} and {"}residual-deficit brain regions,{"} respectively, for aripiprzole monotherapy in MDD.",
author = "Lai, {Chien Han} and Wu, {Yu Te} and Chen, {Cheng Yu} and Hou, {Yi Cheng}",
year = "2016",
month = "8",
day = "1",
doi = "10.1097/MD.0000000000004654",
language = "English",
volume = "95",
pages = "e4654",
journal = "Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries",
issn = "0025-7974",
publisher = "Lippincott Williams and Wilkins",
number = "34",

}

TY - JOUR

T1 - Gray matter increases in fronto-parietal regions of depression patients with aripiprazole monotherapy

T2 - An exploratory study

AU - Lai, Chien Han

AU - Wu, Yu Te

AU - Chen, Cheng Yu

AU - Hou, Yi Cheng

PY - 2016/8/1

Y1 - 2016/8/1

N2 - We investigated the treatment effects of aripiprazole monotherapy in first-episode medication-naïve patients with major depressive disorder (MDD). The accompanying changes in the gray matter volume (GMV) were also explored.Fifteen patients completed the trial and received structural scans by 3-Tesla magnetic resonance imaging at baseline and partially responding state (sixth week). To account for the test-retest bias, 27 healthy controls were scanned twice within 6 weeks. We utilized optimized voxel-based morphometry with different comparisons between groups.The partially responding patients with MDD had greater GMV in left middle frontal gyrus and left superior parietal gyrus when compared with baseline. However, they had decreases in the GMV of right orbitofrontal gyrus and right inferior temporal gyrus after response. The partially responding patients with MDD still had residual GMV deficits in right superior frontal gyrus when compared with controls. However, the lack of second patient group without aripiprazole intervention would be a significant limitation to interpret the aripiprazole-specific effects on GMV.The changes in the GMV of fronto-parieto-temporal regions and residual GMV deficits in the superior frontal gyrus might represent "state-dependent brain changes" and "residual-deficit brain regions," respectively, for aripiprzole monotherapy in MDD.

AB - We investigated the treatment effects of aripiprazole monotherapy in first-episode medication-naïve patients with major depressive disorder (MDD). The accompanying changes in the gray matter volume (GMV) were also explored.Fifteen patients completed the trial and received structural scans by 3-Tesla magnetic resonance imaging at baseline and partially responding state (sixth week). To account for the test-retest bias, 27 healthy controls were scanned twice within 6 weeks. We utilized optimized voxel-based morphometry with different comparisons between groups.The partially responding patients with MDD had greater GMV in left middle frontal gyrus and left superior parietal gyrus when compared with baseline. However, they had decreases in the GMV of right orbitofrontal gyrus and right inferior temporal gyrus after response. The partially responding patients with MDD still had residual GMV deficits in right superior frontal gyrus when compared with controls. However, the lack of second patient group without aripiprazole intervention would be a significant limitation to interpret the aripiprazole-specific effects on GMV.The changes in the GMV of fronto-parieto-temporal regions and residual GMV deficits in the superior frontal gyrus might represent "state-dependent brain changes" and "residual-deficit brain regions," respectively, for aripiprzole monotherapy in MDD.

UR - http://www.scopus.com/inward/record.url?scp=85011967227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011967227&partnerID=8YFLogxK

U2 - 10.1097/MD.0000000000004654

DO - 10.1097/MD.0000000000004654

M3 - Article

VL - 95

SP - e4654

JO - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

JF - Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries

SN - 0025-7974

IS - 34

ER -